Literature DB >> 35586539

Hyperpigmentation Probably Related to Haloperidol in a Patient with Neuroacanthocytosis.

Anumeha Mishra1, Sanjay Pandey1.   

Abstract

Entities:  

Keywords:  haloperidol; hyperpigmentation; neuroacanthocytosis

Year:  2022        PMID: 35586539      PMCID: PMC9092737          DOI: 10.1002/mdc3.13440

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


× No keyword cloud information.
  7 in total

1.  Dopamine D4 receptor antagonist inhibits melanogenesis through transcriptional downregulation of MITF via ERK signalling.

Authors:  Joon Min Jung; Su Yeon Kim; Woo Jin Lee; Jae Sung Hwang; Sung Eun Chang
Journal:  Exp Dermatol       Date:  2016-02-26       Impact factor: 3.960

2.  Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse.

Authors:  S A Burchill; A J Thody
Journal:  J Endocrinol       Date:  1986-11       Impact factor: 4.286

Review 3.  Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.

Authors:  P Seeman; T Tallerico
Journal:  Mol Psychiatry       Date:  1998-03       Impact factor: 15.992

4.  Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.

Authors:  T R Thompson; S Lal; R Yassa; W Gerstein
Journal:  Acta Psychiatr Scand       Date:  1988-12       Impact factor: 6.392

Review 5.  Drug-Induced Hyperpigmentation: Review and Case Series.

Authors:  Rosa M Giménez García; Sergio Carrasco Molina
Journal:  J Am Board Fam Med       Date:  2019 Jul-Aug       Impact factor: 2.657

6.  Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.

Authors:  Y G Gelders
Journal:  Int Clin Psychopharmacol       Date:  1986-07       Impact factor: 1.659

Review 7.  Role of Amine Neurotransmitters and Their Receptors in Skin Pigmentation: Therapeutic Implication.

Authors:  Enkhmend Enkhtaivan; Chang Hoon Lee
Journal:  Int J Mol Sci       Date:  2021-07-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.